相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A mild TCEP-based para-azidobenzyl cleavage strategy to transform reversible cysteine thiol labelling reagents into irreversible conjugates
Antoine Maruani et al.
CHEMICAL COMMUNICATIONS (2015)
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Antoine Maruani et al.
NATURE COMMUNICATIONS (2015)
Bridging Disulfides for Stable and Defined Antibody Drug Conjugates
George Badescu et al.
BIOCONJUGATE CHEMISTRY (2014)
Regioselective and Stoichiometrically Controlled Conjugation of Photodynamic Sensitizers to a HER2 Targeting Antibody Fragment
Francesca Bryden et al.
BIOCONJUGATE CHEMISTRY (2014)
Production of Site-Specific Antibody-Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System
Erik S. Zimmerman et al.
BIOCONJUGATE CHEMISTRY (2014)
Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging
Felix F. Schumacher et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Antibody-Drug Conjugates for the Treatment of Cancer
John A. Flygare et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2013)
Acid-cleavable thiomaleamic acid linker for homogeneous antibody-drug conjugation
Lourdes Castaneda et al.
CHEMICAL COMMUNICATIONS (2013)
Maturing antibody-drug conjugate pipeline hits 30
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2013)
Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'
Felix F. Schumacher et al.
SCIENTIFIC REPORTS (2013)
Antibody-drug conjugates - a perfect synergy
John R. Adair et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
Ben-Quan Shen et al.
NATURE BIOTECHNOLOGY (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation
Felix F. Schumacher et al.
BIOCONJUGATE CHEMISTRY (2011)
Tunable reagents for multi-functional bioconjugation: reversible or permanent chemical modification of proteins and peptides by control of maleimide hydrolysis
Chris P. Ryan et al.
CHEMICAL COMMUNICATIONS (2011)
Bromopyridazinedione-mediated protein and peptide bioconjugation
Vijay Chudasama et al.
CHEMICAL COMMUNICATIONS (2011)
Investigational antibody drug conjugates for solid tumors
Puja Sapra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Antibody-Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies
Laurent Ducry et al.
BIOCONJUGATE CHEMISTRY (2010)
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Jagath R. Junutula et al.
CLINICAL CANCER RESEARCH (2010)
Antibody-drug conjugates: targeted drug delivery for cancer
Stephen C. Alley et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2010)
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides
Mark E. B. Smith et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Jagath R. Junutula et al.
NATURE BIOTECHNOLOGY (2008)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
分享论文
